Home
MAZE
MAZE News

Latest MAZE THERAPEUTICS INC (MAZE) News on May 14, 2025

Maze Therapeutics to Participate in the 3rd Annual H.C. Wainwright BioConnect Investor Conference

GlobeNewswire

a day ago

Maze Therapeutics to Participate in the 3rd Annual H.C. Wainwright BioConnect Investor Conference

US Market's Undiscovered Gems Featuring ZJK Industrial And 2 More Small Caps

Simply Wall St.

a month ago

US Market's Undiscovered Gems Featuring ZJK Industrial And 2 More Small Caps

Maze Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Highlights

GlobeNewswire

a month ago

Maze Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Highlights

Investing.com

3 months ago

Maze Therapeutics receives positive ratings following recent IPO

Maze Therapeutics doses first subject in Phase II AKD treatment trial

Clinical Trials Arena

3 months ago

Maze Therapeutics doses first subject in Phase II AKD treatment trial

Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease

GlobeNewswire

3 months ago

Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease

MT Newswires

3 months ago

Maze Therapeutics Prices Upsized IPO at $16 Per Share

Drugmakers Metsera and Maze Raise Combined $415 Million in IPOs

Bloomberg

3 months ago

Drugmakers Metsera and Maze Raise Combined $415 Million in IPOs

Maze Therapeutics Announces Pricing of Upsized Initial Public Offering

GlobeNewswire

3 months ago

Maze Therapeutics Announces Pricing of Upsized Initial Public Offering

Metsera, Maze secure combined $415 million in IPOs

BioPharma Dive

3 months ago

Metsera, Maze secure combined $415 million in IPOs

Share on Social Networks: